会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • PEPTIDE ZUR VAKZINIERUNG GEGEN DAS HUMANE CMV
    • 肽疫苗接种反对人类巨细胞病毒
    • EP1181313A2
    • 2002-02-27
    • EP00945603.9
    • 2000-06-02
    • Kern, Florian
    • KERN, FlorianVOLK, Hans-DieterREINKE,PetraFAULHABER, NicoleSUREL, Ingolf-PascalKHATAMZAS, Elham
    • C07K14/045A61K39/25C12N15/38C12N15/63G01N33/68
    • C07K14/005A61K39/00C12N2710/16122C12N2710/16134Y02P20/55
    • The invention relates to peptides which are optionally fragments of the IE-1 or pp65 protein selected from the following group having sequence RN - Gln Thr Met Leu Arg Lys Glu Val Asn Ser Gln Leu Ser Leu Gly - RC; RN - Cys Asn Glu Asn Pro Glu Lys Asp Val Leu Ala Glu Leu Val Lys - RC; RN - Leu Val Lys Gln Ile Lys Val Arg Val Asp Met Val Arg His Arg - RC; RN - Ala Ala Asn Lys Leu Gly Gly Ala Leu Gln Ala Lys Ala Arg Ala - RC; RN - Ala Arg Ala Lys Lys Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Glu Leu Arg Arg Lys Met Met Tyr Met Cys Tyr Arg Asn Ile Glu - RC; RN - Val Thr Ser Asp Ala Cys Met Met Thr Met Tyr Gly Gly Ile Ser - RC; RN - Glu Phe Cys Arg Val Leu Cys Cys Tyr Val Leu Glu Glu Thr Ser - RC; RN - Met Ser Ile Tyr Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile - RC; RN - Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile Pro Ser Ile Asn - RC; RN - Ala Leu Pro Leu Lys Met Leu Asn Ile - RC; RN - His Ile Met Leu Asp Val Ala Phe Thr Ser His Glu His Phe Gly RC; RN - Asp Val Ala Phe Thr Ser His Glu His Phe Gly Leu Leu Cys Pro - RC; RN - Val Ala Phe Thr Ser His Glu His Phe - RC; RN - Ala Phe Thr Ser His Glu His Phe Gly - RC; RN - Ala Asn Asp Ile Tyr Arg Ile Phe Ala Glu Leu Glu Gly Val Trp - RC; RN - Val Cys Ser Met Glu Asn Thr Arg Ala Thr Lys Met Gln Val Ile - RC; RN - Glu Asn Thr Arg Ala Thr Lys Met Gln Val Ile Gly Asp Gln Tyr - RC; RN - Asn Thr Arg Ala Thr Lys Met Gln Val - RC; RN - Thr Arg Ala Thr Lys Met Gln Val Ile - RC; RN - Gln Pro Phe Met Arg Pro His Glu Arg Asn Gly Phe Thr Val Leu - RC; RN - Pro Leu Lys Met Leu Asn Ile Pro Ser Ile Asn Val His His Tyr - RC; RN - Leu Asn Ile Pro Ser Ile Asn Val His His Tyr Pro Ser Ala Ala - RC; RN Glu Asp Val Pro Ser Glu Lys Leu Phe Met His Val Thr Leu Gly - RC; RN - Cys Arg Val Leu Cys Cys Tyr Val Leu - RC; RN - Arg Val Leu Cys Cys Tyr Val Leu Glu - RC; RN - Val Leu Cys Cys Tyr Val Leu Glu Glu - RC; RN - Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Leu Arg Arg Lys Met Met Tyr - RC; RN Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Glu Glu Ala Ile Val Ala Tyr Tyr Leu Ala Thr Ala Gly - RC or RN - Glu Asn Ser Asp Gln Glu Ser Glu Gln Ser Asp Glu Glu Glu - RC, whereby RN represents -H or an amino protecting group; RC represents -OH or a carboxyl protecting group. The inventive peptides are used in the preparation of a medicaments for vaccination against HVMV infections or a diagnostic reagent for identifying an immune response against HCMV.
    • 5. 发明授权
    • PEPTIDE ZUR VAKZINIERUNG GEGEN DAS HUMANE CMV
    • 肽疫苗接种反对人类巨细胞病毒
    • EP1181313B1
    • 2011-02-09
    • EP00945603.9
    • 2000-06-02
    • Kern, Florian
    • KERN, FlorianVOLK, Hans-DieterREINKE,PetraFAULHABER, NicoleSUREL, Ingolf-PascalKHATAMZAS, Elham
    • C07K14/045A61K39/25C12N15/38C12N15/63G01N33/68
    • C07K14/005A61K39/00C12N2710/16122C12N2710/16134Y02P20/55
    • The invention relates to peptides which are optionally fragments of the IE-1 or pp65 protein selected from the following group having sequence RN - Gln Thr Met Leu Arg Lys Glu Val Asn Ser Gln Leu Ser Leu Gly - RC; RN - Cys Asn Glu Asn Pro Glu Lys Asp Val Leu Ala Glu Leu Val Lys - RC; RN - Leu Val Lys Gln Ile Lys Val Arg Val Asp Met Val Arg His Arg - RC; RN - Ala Ala Asn Lys Leu Gly Gly Ala Leu Gln Ala Lys Ala Arg Ala - RC; RN - Ala Arg Ala Lys Lys Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Glu Leu Arg Arg Lys Met Met Tyr Met Cys Tyr Arg Asn Ile Glu - RC; RN - Val Thr Ser Asp Ala Cys Met Met Thr Met Tyr Gly Gly Ile Ser - RC; RN - Glu Phe Cys Arg Val Leu Cys Cys Tyr Val Leu Glu Glu Thr Ser - RC; RN - Met Ser Ile Tyr Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile - RC; RN - Val Tyr Ala Leu Pro Leu Lys Met Leu Asn Ile Pro Ser Ile Asn - RC; RN - Ala Leu Pro Leu Lys Met Leu Asn Ile - RC; RN - His Ile Met Leu Asp Val Ala Phe Thr Ser His Glu His Phe Gly RC; RN - Asp Val Ala Phe Thr Ser His Glu His Phe Gly Leu Leu Cys Pro - RC; RN - Val Ala Phe Thr Ser His Glu His Phe - RC; RN - Ala Phe Thr Ser His Glu His Phe Gly - RC; RN - Ala Asn Asp Ile Tyr Arg Ile Phe Ala Glu Leu Glu Gly Val Trp - RC; RN - Val Cys Ser Met Glu Asn Thr Arg Ala Thr Lys Met Gln Val Ile - RC; RN - Glu Asn Thr Arg Ala Thr Lys Met Gln Val Ile Gly Asp Gln Tyr - RC; RN - Asn Thr Arg Ala Thr Lys Met Gln Val - RC; RN - Thr Arg Ala Thr Lys Met Gln Val Ile - RC; RN - Gln Pro Phe Met Arg Pro His Glu Arg Asn Gly Phe Thr Val Leu - RC; RN - Pro Leu Lys Met Leu Asn Ile Pro Ser Ile Asn Val His His Tyr - RC; RN - Leu Asn Ile Pro Ser Ile Asn Val His His Tyr Pro Ser Ala Ala - RC; RN Glu Asp Val Pro Ser Glu Lys Leu Phe Met His Val Thr Leu Gly - RC; RN - Cys Arg Val Leu Cys Cys Tyr Val Leu - RC; RN - Arg Val Leu Cys Cys Tyr Val Leu Glu - RC; RN - Val Leu Cys Cys Tyr Val Leu Glu Glu - RC; RN - Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Leu Arg Arg Lys Met Met Tyr - RC; RN Asp Glu Leu Arg Arg Lys Met Met Tyr Met - RC; RN - Asp Glu Glu Glu Ala Ile Val Ala Tyr Tyr Leu Ala Thr Ala Gly - RC or RN - Glu Asn Ser Asp Gln Glu Ser Glu Gln Ser Asp Glu Glu Glu - RC, whereby RN represents -H or an amino protecting group; RC represents -OH or a carboxyl protecting group. The inventive peptides are used in the preparation of a medicaments for vaccination against HVMV infections or a diagnostic reagent for identifying an immune response against HCMV.